K. Huygen, Prospects for vaccine development against Buruli disease, Expert Review of Vaccines, vol.2, issue.4, pp.561-569, 2003.
DOI : 10.1586/14760584.2.4.561

M. Wansbrough-jones and R. Phillips, Buruli ulcer: emerging from obscurity, The Lancet, vol.367, issue.9525, pp.1849-1858, 2006.
DOI : 10.1016/S0140-6736(06)68807-7

C. Demangel, T. Stinear, and S. Cole, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009.
DOI : 10.1093/molbev/msm092

J. Guarner, J. Bartlett, E. Whitney, P. Raghunathan, and Y. Stienstra, Infection, Emerging Infectious Diseases, vol.9, issue.6, pp.651-656, 2003.
DOI : 10.3201/eid0906.020485

K. Asiedu and M. Wansbrough-jones, Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies, Med J Aust, vol.186, pp.55-56, 2007.

S. Etuaful, B. Carbonnelle, J. Grosset, S. Lucas, and C. Horsfield, Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3182-3186, 2005.
DOI : 10.1128/AAC.49.8.3182-3186.2005

B. Ji, S. Lefrancois, J. Robert, A. Chauffour, and C. Truffot, In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans, Antimicrobial Agents and Chemotherapy, vol.50, issue.6, pp.1921-1926, 2006.
DOI : 10.1128/AAC.00052-06

P. Johnson, Should antibiotics be given for Buruli ulcer?, The Lancet, vol.375, issue.9715, pp.618-619, 2010.
DOI : 10.1016/S0140-6736(10)60169-9

F. Sarfo, R. Phillips, K. Asiedu, E. Ampadu, and N. Bobi, Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3678-3685, 2010.
DOI : 10.1128/AAC.00299-10

W. Nienhuis, Y. Stienstra, K. Abass, W. Tuah, and W. Thompson, Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection, Clinical Infectious Diseases, vol.54, issue.4, pp.519-526, 2012.
DOI : 10.1093/cid/cir856

L. Guenin-mace, R. Oldenburg, F. Chretien, and C. Demangel, Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens. Cellular and Molecular Life Sciences: doi.org/10, pp.18-32, 1007.
URL : https://hal.archives-ouvertes.fr/pasteur-01387237

H. Hong, C. Demangel, S. Pidot, P. Leadlay, and T. Stinear, Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Natural Product Reports, vol.45, issue.3, pp.447-454, 2008.
DOI : 10.1039/b803101k

K. George, D. Chatterjee, G. Gunawardana, D. Welty, and J. Hayman, Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999.
DOI : 10.1126/science.283.5403.854

S. Boulkroun, L. Guenin-mace, M. Thoulouze, M. Monot, and A. Merckx, Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events, The Journal of Immunology, vol.184, issue.3, pp.1436-1444, 2010.
DOI : 10.4049/jimmunol.0902854
URL : https://hal.archives-ouvertes.fr/pasteur-00594632

E. Coutanceau, J. Decalf, A. Martino, A. Babon, and N. Winter, toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007.
DOI : 10.1016/0022-1759(94)90236-4
URL : https://hal.archives-ouvertes.fr/pasteur-01402321

E. Coutanceau, L. Marsollier, R. Brosch, E. Perret, and P. Goossens, Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cellular Microbiology, vol.34, issue.8, pp.1187-1196, 2005.
DOI : 10.1016/S0140-6736(99)01156-3

L. Guenin-mace, F. Carrette, F. Asperti-boursin, L. Bon, A. Caleechurn et al., Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression, Proceedings of the National Academy of Sciences, vol.108, issue.31, pp.12833-12838, 2011.
DOI : 10.1073/pnas.1016496108
URL : https://hal.archives-ouvertes.fr/pasteur-00738806

A. Pahlevan, D. Wright, C. Andrews, K. George, and P. Small, The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999.

R. Simmonds, F. Lali, T. Smallie, P. Small, and B. Foxwell, Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism, The Journal of Immunology, vol.182, issue.4, pp.2194-2202, 2009.
DOI : 10.4049/jimmunol.0802294

R. Phillips, F. Sarfo, L. Guenin-mace, J. Decalf, and M. Wansbrough-jones, Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease, The Journal of Infectious Diseases, vol.200, issue.11, pp.1675-84, 2009.
DOI : 10.1086/646615
URL : https://hal.archives-ouvertes.fr/pasteur-01402286

R. Phillips, C. Horsfield, S. Kuijper, A. Lartey, and I. Tetteh, Sensitivity of PCR Targeting the IS2404 Insertion Sequence of Mycobacterium ulcerans in an Assay Using Punch Biopsy Specimens for Diagnosis of Buruli Ulcer, Journal of Clinical Microbiology, vol.43, issue.8, pp.3650-3656, 2005.
DOI : 10.1128/JCM.43.8.3650-3656.2005

J. Trygg and S. Wold, Orthogonal projections to latent structures (O-PLS), Journal of Chemometrics, vol.10, issue.3, pp.119-128, 2002.
DOI : 10.1002/cem.695

Y. Benjamini and Y. Hochberg, Controlling the False Discovery Rate -a Practical and Powerful Approach to Multiple Testing, Journal of the Royal Statistical Society Series B-Methodological, vol.57, pp.289-300, 1995.

J. Storey, A direct approach to false discovery rates, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.82, issue.3, pp.479-498, 2002.
DOI : 10.1111/1467-9868.00346

E. Peresi, S. Silva, S. Calvi, and J. Marcondes-machado, Cytokines and acute-phase serum proteins as markers of inflammatory regression during pulmonary tuberculosis treatment, Journal of Venomous Animals and Toxins including Tropical Diseases, vol.14, issue.1, pp.942-949, 2008.
DOI : 10.1590/S1678-91992008000100019

F. Van-de-goot, P. Krijnen, M. Begieneman, M. Ulrich, and E. Middelkoop, Acute Inflammation is Persistent Locally in Burn Wounds: A Pivotal Role for Complement and C-Reactive Protein, Journal of Burn Care & Research, vol.30, issue.2, pp.274-280, 2009.
DOI : 10.1097/BCR.0b013e318198a252

D. Gore, D. Chinkes, S. Wolf, A. Sanford, and D. Herndon, for Skin, Wound, and Muscle in Severe Burn Patients, Journal of Parenteral and Enteral Nutrition, vol.30, issue.4, pp.331-338, 2006.
DOI : 10.1177/0148607106030004331

B. Meijer, R. Gearry, and A. Day, The Role of S100A12 as a Systemic Marker of Inflammation, International Journal of Inflammation, vol.75, issue.4, p.907078, 2012.
DOI : 10.1136/gut.2009.194100

D. Yeboah-manu, E. Peduzzi, E. Mensah-quainoo, A. Asante-poku, and D. Ofori-adjei, Systemic suppression of interferon-?? responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, Journal of Leukocyte Biology, vol.79, issue.6, pp.1150-1156, 2006.
DOI : 10.1189/jlb.1005581

A. Fraga, A. Cruz, T. Martins, E. Torrado, and M. Saraiva, Mycobacterium ulcerans Triggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression, Infection and Immunity, vol.79, issue.1, pp.421-430, 2011.
DOI : 10.1128/IAI.00820-10

F. Sarfo, L. Chevalier, F. Aka, N. Phillips, R. Amoako et al., Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring, PLoS Neglected Tropical Diseases, vol.9, issue.7, p.1237, 2011.
DOI : 10.1371/journal.pntd.0001237.t001
URL : https://hal.archives-ouvertes.fr/inserm-00691438

H. Hong, E. Coutanceau, M. Leclerc, L. Caleechurn, and P. Leadlay, Mycolactone Diffuses from Mycobacterium ulcerans???Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs, PLoS Neglected Tropical Diseases, vol.23, issue.10, p.325, 2008.
DOI : 10.1371/journal.pntd.0000325.g006

F. Sarfo, P. Converse, D. Almeida, J. Zhang, and C. Robinson, Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease, PLoS Neglected Tropical Diseases, vol.5, issue.3, p.2101, 2013.
DOI : 10.1371/journal.pntd.0002101.t001

F. Sarfo, R. Phillips, B. Rangers, E. Mahrous, and R. Lee, Detection of Mycolactone A/B in Mycobacterium ulcerans???Infected Human Tissue, PLoS Neglected Tropical Diseases, vol.2, issue.1, p.577, 2010.
DOI : 10.1371/journal.pntd.0000577.t001

E. Park, J. Lee, G. Yu, G. He, and S. Ali, Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression, Cell, vol.140, issue.2, pp.197-208, 2010.
DOI : 10.1016/j.cell.2009.12.052

M. Posthauer, The Role of Nutrition in Wound Care, Advances in Skin & Wound Care, vol.19, issue.1, pp.62-63, 2012.
DOI : 10.1097/00129334-200601000-00014